A new opportunity has arisen to overturn ALDF v Quigg, the case testing the validity of patents on all non-human animals.
Prolume v Gentarget et al.is outlined below:
Infringement
|
Court : U.S. District Court for the Southern District of California
|
Presided by: William Q. Hayes
|
Civil Action No: 3:13-cv-00130-WQH-BLM
|
Defendant(s) :
1. Gentarget, Inc.
2. Genprice, Inc.
3. Amsbio LLC
4. BST Scientific PTE LTD
5. Gentaur Molecular Products BVBA
6. Filgen Biosciences, Inc.
7. Does 1 through 10, Inclusive
|
Plaintiff(s) :
Prolume, LTD. — represented by
Law Offices of Philip J Kaplan; Los Angeles, CA Attorneys: Philip Jeremy Kaplan |
Patent(s) in Suit :
|
|
6,232,107
 |
Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent
by Bryan et. al. |
7,109,315
|
Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins
by Bryan et. al. |
The lawsuit reeks of the the "indicia of extortion."
Additionally since the patents claim animal genes (aquatic life) a defense might be the invalidity of patents for the reasons argued by ALDF against then-Commissioner Donald Quigg, supporting the Patent Office. For details see the post on my blog: (http://www.koshergoldfish.com/ethics_of_biotechnology.html)
"Other Peoples Bodies."
GenTarget Inc, 6640 Lusk Blvd. Suite A107, San Diego, USA(858)678-8683
No comments:
Post a Comment